 |
20+ clients ranging from small to large-sized pharma and biotech in US, Europe and Asia
|
|
|
Projects in varied therapeutic areas (Endocrine,
CNS, Oncology, Cardio-Renal, Metabolic,
Antiviral) |
|
|
Long-term client relationships built on
performance, contribution and trust.
|
|
|
Authored multiple nonclinical IND and
NDA eCTD submissions.
|
|
|
Developed strategies to evaluate toxicity of
drug candidates and drug product formulations
consistent with current regulatory standards
|
|
|
Justified presence of novel excipients in
formulations and/or developed programs to qualify novel
formulation excipients
|
|
|
Designed and monitored toxicology studies at
CRO’s and reviewed/revised reports
|
|
|
Performed preclinical diligence and gap analysis on in-licensing
candidates for pharma companies and investment
firms |
